These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8087515)

  • 1. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
    Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Douillard JY; Tarayre M; Lacombe-Terrier MJ; Laplanche A
    Lung Cancer; 1994 Mar; 10 Suppl 1():S239-44. PubMed ID: 8087515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
    Arriagada R; Le Chevalier T; Quoix E; Ruffie P; de Cremoux H; Douillard JY; Tarayre M; Pignon JP; Laplanche A
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1183-90. PubMed ID: 1646194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
    Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Tarayre M; Lacombe-Terrier MJ; Douillard JY; Laplanche A
    J Natl Cancer Inst; 1991 Mar; 83(6):417-23. PubMed ID: 1847977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma?
    Thomas F; Le Chevalier T; Arriagada R; Ruffié P; Baldeyrou P
    Antibiot Chemother (1971); 1988; 41():138-41. PubMed ID: 2854433
    [No Abstract]   [Full Text] [Related]  

  • 5. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial.
    Gregor A; Macbeth FR; Paul J; Cram L; Hansen HH
    J Natl Cancer Inst; 1993 Jun; 85(12):997-9. PubMed ID: 7684456
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
    Tsuchiya S; Ohe Y; Sugiura T; Fuwa N; Kitamoto Y; Mori K; Kobayashi H; Nakata K; Sawa T; Hirai K; Etoh T; Saka H; Saito A; Fukuda H; Ishizuka N; Saijo N;
    Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
    Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Duroux P; Jacquotte A; Sancho-Garnier H; Rouesse J
    Cancer Treat Rep; 1985 May; 69(5):469-72. PubMed ID: 4039979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
    Chhajed PN; Baty F; Pless M; Somandin S; Tamm M; Brutsche MH
    Chest; 2006 Dec; 130(6):1803-7. PubMed ID: 17167000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].
    Nasr E; Pellae-Cosset B; Arriagada R; Le Chevalier T; Baldeyrou P; Ruffie P; de Cremoux H; Martin M; Tarayre M
    Bull Cancer; 1992; 79(7):681-7. PubMed ID: 1334740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
    Tejedor M; Valerdi JJ; López R; Domínguez MA; Arias F; Illarramendi JJ; Martínez E
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):813-8. PubMed ID: 7860393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
    Wolf M; Hans K; Becker H; Hässler R; von Bültzingslöwen F; Goerg R; Klaasen HA; Dannhäuser J; Holle R; Pfab R
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
    Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
    J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.
    Kim TY; Yang SH; Lee SH; Park YS; Im YH; Kang WK; Ha SH; Park CI; Heo DS; Bang YJ; Kim NK
    Am J Clin Oncol; 2002 Jun; 25(3):238-43. PubMed ID: 12040280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.
    Morton RF; Jett JR; McGinnis WL; Earle JD; Therneau TM; Krook JE; Elliott TE; Mailliard JA; Nelimark RA; Maksymiuk AW
    Ann Intern Med; 1991 Nov; 115(9):681-6. PubMed ID: 1656827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].
    Rieber A; Brambs HJ; Kauffmann G; Wannenmacher M; Drings P
    Strahlenther Onkol; 1991 Jan; 167(1):14-8. PubMed ID: 1846982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.